Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Cancer chemoprevention.

¹Departments of Internal Medicine and Pharmacology, 3-216 Comprehensive Cancer Center, University of Michigan Medical Center and VA Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 48109-0934, USA.

Current Opinion in Gastroenterology

|October 7, 2006

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Low Prevalence of Screen-Detected Colorectal Cancer in an Average-Risk Population: The New Normal.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2021

Same author

A phase I/II pharmacokinetic and pharmacogenomic study of calcitriol in combination with cisplatin and docetaxel in advanced non-small-cell lung cancer.

Cancer chemotherapy and pharmacology·2013

Same author

Cancer chemoprevention: lessons learned and future directions.

British journal of cancer·2005

Same author

New paradigms in oncological therapeutics: redefining combination chemotherapy.

Annals of oncology : official journal of the European Society for Medical Oncology·2002

Same author

Expression of 12-lipoxygenase as a biomarker for melanoma carcinogenesis.

Melanoma research·2002

Same author

Clinical and economic impact of multiple gated acquisition scan monitoring during anthracycline therapy.

British journal of cancer·2002

Same journal

Endoscopic techniques to minimize gastroesophageal reflux during peroral endoscopic myotomy.

Current opinion in gastroenterology·2026

Same journal

Postendoscopy esophageal adenocarcinoma and neoplasia: current status and future directions.

Current opinion in gastroenterology·2026

Same journal

The complement system in inflammatory bowel disease: from early observations to emerging frontiers.

Current opinion in gastroenterology·2026

Same journal

Goblet cell-associated antigen passages in health and disease.

Current opinion in gastroenterology·2026

Same journal

Inflammatory bowel diseases 2026: form, function and therapeutic considerations for the epithelial barrier.

Current opinion in gastroenterology·2026

Same journal

Dietary protein as a regulator of colitis and colorectal cancer.

Current opinion in gastroenterology·2026

See all related articles

Nonsteroidal anti-inflammatory drugs show promise for lower intestine chemoprevention. Future nutritional approaches may involve personalized assessments of individual metabolism and bioavailability for enhanced efficacy.

Area of Science:

Oncology
Gastroenterology
Nutritional Science

Background:

Chemoprevention strategies aim to prevent or delay cellular transformation using nutritional or pharmaceutical agents.
Nonsteroidal anti-inflammatory drugs (NSAIDs) have garnered significant research interest for their chemopreventive effects in the lower intestine.
Recent studies explore novel compounds from natural sources like citrus and Asian foods for their therapeutic potential.

Purpose of the Study:

To review recent advancements in chemoprevention research, focusing on NSAIDs and natural compounds.
To address the efficacy of micronutrients as chemopreventive agents.
To explore future directions in personalized nutritional chemoprevention.

Main Methods:

Review of preclinical and clinical studies on NSAIDs and natural compounds for chemoprevention.

Related Experiment Videos

Analysis of clinical trial data regarding micronutrient efficacy.

Discussion of pharmacologic approaches for assessing individual nutrient metabolism.

Main Results:

Continued research and publications highlight the promise of NSAIDs in lower intestinal chemoprevention.
New preclinical data suggest potential clinical benefits from citrus-derived and Asian food compounds.
Clinical trials indicate a lack of efficacy for previously predicted micronutrient chemopreventives.

Conclusions:

NSAIDs remain a key focus for lower intestinal chemoprevention research.
Natural compounds show promise, warranting further clinical investigation.
Personalized nutritional strategies, considering individual bioavailability and metabolism, may offer future advancements in chemoprevention.